|1|Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? (24191126)
Anastasi E.... Porpora M.G.
|2|Recurrent epithelial ovarian cancer and hormone therapy. (24303498)
Yokoyama Y.... Mizunuma H.
|3|Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach. (24080421)
Feuer G.A.... Burrell M.
|4|Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance. (23652306)
Palmieri C.... Faratian D.
|5|The impact of pelvic retroperitoneal invasion and distant nodal metastases in epithelial ovarian cancer. (24183480)
Pereira A.... Ortiz-Quintana L.
|6|EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1. (24335192)
Li T.... Wang Z.
|7|Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer. (24377084)
Konstantinopoulos P.A.... Matulonis U.A.
|8|BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. (22685580)
Le Page C.... Cailhier J.F.
|9|The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer. (22818908)
Gui T.... Shen K.
|10|ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells. (22232246)
Peng J.... Zhang A.
|11|Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via I^1 integrin and PTEN signals. (23013730)
Shen Y.... Li F.
|12|Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer. (21559368)
Tseng C.H.... Huang P.H.
|13|Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer. (21955482)
Bondurant A.E.... Murphy S.K.
|14|Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFA,B pathway. (21623171)
Chefetz I.... Mor G.
|15|Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer. (20973260)
Li Y.... Zhao L.
|16|Significance of preoperative thrombocytosis in epithelial ovarian cancer. (20090223)
Crasta J.A.... Rameshkumar K.
|17|Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer. (20670949)
Fu M.... Wadehra M.
|18|Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: the involvement of specific conformational states of beta-actin. (20596672)
Cicchillitti L.... Scambia G.
|19|Protease inhibitor SERPINA1 expression in epithelial ovarian cancer. (20049513)
Normandin K.... Mes-Masson A.M.
|20|E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer. (20181230)
Kothandaraman N.... Choolani M.
|21|Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells. (20196847)
Bryant C.S.... Batchu R.B.
|22|Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. (20158306)
White K.L.... Goode E.L.
|23|The clinicopathological characteristics of 'triple-negative' epithelial ovarian cancer. (20203223)
Liu N.... Sheng X.
|24|Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass. (19101713)
Karam A.K.... Gemignani M.L.
|25|Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. (19692629)
Jung Y.W.... Kim J.W.
|26|Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value]. (18366924)
Tan X.J.... Xu X.Y.
|27|S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. (18513786)
Devine K.M.... Fishman D.A.
|28|Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells]. (17697603)
Jiang Y.P.... DU X.Y.
|29|Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). (17617155)
Belisle J.A.... Patankar M.S.
|30|Antisense suppression of pygopus2 results in growth arrest of epithelial ovarian cancer. (16609037)
Popadiuk C.M.... Kao K.R.
|31|Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. (16777976)
Cheung L.W.... Wong A.S.
|32|Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression. (17107625)
Rask K.... Sundfeldt K.
|33|Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma. (16126263)
Erkinheimo T.L.... RistimAoki A.
|34|RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women. (15670896)
Kelemen L.... Chenevix-Trench G.
|35|Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. (15774616)
MacciA^ A.... Mantovani G.
|36|Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. (15734951)
Baron A.T.... Maihle N.J.
|37|Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer. (15350362)
Kalli K.R.... Conover C.A.
|38|Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer. (14645425)
Hussain M.M.... Kohn E.C.
|39|Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. (11821951)
Liu Y.... Ganesan T.S.
|40|Advances in the management of epithelial ovarian cancer. (11499181)
Memarzadeh S.... Berek J.S.
|41|The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. (10577927)
Stratton J.F.... Ponder B.A.
|42|Cyclin D1 overexpression and p53 mutation status in epithelial ovarian cancer. (10205781)
Shigemasa K.... O'Brien T.J.
|43|Characteristics and growth patterns of human peritoneal mesothelial cells: comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources. (10643588)
Zhang X.Y.... Barton D.P.
|44|Association of glutathione S-transferase GSTM1 and GSTT1 null genotypes with clinical outcome in epithelial ovarian cancer. (9796976)
Howells R.E.... Strange R.C.
|45|Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay. (9299253)
Chien C.H.... Chow S.N.
|46|Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer. (9307529)
Ind T.... Chard T.
|47|Sequential granulocyte colony-stimulating factor increases cisplatin cytotoxicity in human epithelial ovarian cancer cell lines. (8774656)
Fanning J.... Medrano C.
|48|First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. (8494710)
Rosen A.... Leodolter S.
|49|The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125. (8494699)
Fisken J.... Leonard R.C.
|50|Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group. (3181261)
van Oosterom A.T.... Vermorken J.B.